Source Compartment | S-Value (111In) (Gy/(Bq × sec) | Panitumumab-DOTA-[111In]In | Panitumumab-MCP-[111In]In | S-Value (177Lu) (Gy/(Bq × sec) | Panitumumab-DOTA-[177Lu]Lu | |||
---|---|---|---|---|---|---|---|---|
Ãs (Bq × sec) | Dose (Gy) | Ãs (Bq × sec) | Dose (Gy) | Ãs (Bq × sec) | Dose (Gy) | |||
CS | 7.35 × 10−5 | 9.24 × 103 | 0.68 | 2.67 × 103 | 0.20 | 3.55 × 10− 4 | 9.77 × 103 | 3.47 |
Cy | 1.03 × 10− 4 | 1.01 × 103 | 0.10 | 1.16 × 103 | 0.12 | 4.02 × 10− 4 | 1.07 × 103 | 0.43 |
N | 5.06 × 10− 4 | 0.67 × 103 | 0.34 | 0.40 × 103 | 0.20 | 6.93 × 10− 4 | 0.70 × 103 | 0.49 |
Total Ãs (cell; Bq × sec) | 10.92 × 103 | 4.23 × 103 | 11.54 × 103 | |||||
Medium | 1.50 × 10−12 | 5.91 × 1010 | 0.09 | 6.19 × 1010 | 0.09 | 4.72 × 10− 12 | 6.20 × 1010 | 0.29 |
Total dose (cell and medium) | 1.21 | 0.61 | 4.68 | |||||
Major Contributor | CS (56%) | CS/N (30%) | CS (74%) |